Table 2.
Healthy venous |
CVD patients |
Stroke arterial |
|||
---|---|---|---|---|---|
9.0 mL | Cerebral artery | Systemic | Intracranial | p, Systemic vs. Intracranial | |
B cells | 13.15 ± 3.92% | 7.90 ± 2.98% | 10.09 ± 6.20% | 9.13 ± 8.81% | 0.38 |
T cells | 51.59 ± 6.92% | 58.36 ± 14.35% | 44.35 ± 17.03% | 51.53 ± 18.72% | 0.01 |
CD4+ | 23.22 ± 5.52% | 31.49 ± 12.37% | 17.99 ± 7.82% | 21.30 ± 8.26% | 0.02 |
CD8+ | 14.36 ± 6.51% | 10.48 ± 4.55% | 12.12 ± 6.89% | 15.09 ± 8.04% | 0.02 |
Myeloid | 14.96 ± 5.88% | 15.58 ± 6.93% | 24.72 ± 15.27% | 18.46 ± 12.16% | 0.02 |
Monocytes | 2.19 ± 1.21% | 5.10 ± 3.51% | 5.06 ± 4.50% | 5.24 ± 5.50% | 0.86 |
Macrophages | 10.77 ± 4.60% | 9.81 ± 4.09% | 16.98 ± 11.58% | 11.94 ± 8.50% | 0.02 |
Granulocytes | 1.01 ± 2.25% | 0.42 ± 0.35% | 1.89 ± 2.29% | 0.85 ± 0.76% | 0.08 |
Dendritic cells | 1.76 ± 0.68% | 2.72 ± 1.68% | 1.94 ± 1.15% | 2.26 ± 2.89% | 0.63 |
Classical | 0.52 ± 0.25% | 0.32 ± 0.16% | 0.16 ± 0.14% | 0.23 ± 0.39% | 0.50 |
Myeloid | 1.24 ± 0.51% | 2.40 ± 1.65% | 1.78 ± 1.13% | 2.04 ± 2.76% | 0.63 |
NK cells | 23.39 ± 5.76% | 12.43 ± 4.05% | 14.37 ± 6.60% | 15.51 ± 6.94% | 0.41 |
NKT CD8+ CD3+ | 2.56 ± 0.89% | 1.51 ± 1.83% | 2.65 ± 3.30% | 3.44 ± 3.34% | 0.32 |
NK CD8+ CD3− | 4.39 ± 2.13% | 0.94 ± 0.51% | 1.47 ± 1.39% | 1.40 ± 1.25% | 0.35 |
NKT CD3+ | 4.82 ± 1.35% | 0.79 ± 0.95% | 0.66 ± 0.82% | 0.65 ± 0.62% | 0.67 |
NKT CD4+ CD3+ | 3.10 ± 1.65% | 5.93 ± 3.33% | 3.58 ± 2.73% | 4.22 ± 3.18% | 0.03 |
NK | 8.53 ± 3.55% | 3.25 ± 2.15% | 4.88 ± 3.02% | 4.59 ± 3.49% | 0.71 |